GeneXpert® Xpress

Moving Molecular Testing Beyond the Lab

Clinical and Operational Impact

Reduced footprint with built-in barcode scanner and full-size touchscreen

On-demand and randome access with mix-and-match test capabilities for optimal flexibility

Easy printing with simple, remote, printing capabilites

No specialized training and no daily maintenance required

Flexible wired and wireless network connection capabilities

Product Information

Standardized CLIA waived molecular testing for any healthcare setting — from community hospitals to physician offices and specialty clinics

  • Innovative Compact Design — Two or four-module configuration saves valuable bench space and reduces the need for multiple testing platforms.
  • Simplified Control and Oversight — GeneXpert Xpress complements existing laboratory quality and regulatory compliance standards.
  • Proven Cartridge Technology — With a combination of highly accurate results and operator ease-of-use, Cepheid’s cartridge technology remains the cornerstone of the GeneXpert Xpress.

US-IVD. In Vitro Diagnostic Medical Device.

GeneXpert® Xpress IV

Available in a 2 or 4 module configuration


11. 5” W x 18” H* x 16” D*

Ordering Info

GeneXpert Xpress IV with 2 active modules

Catalogue number GXIV-2-CLIA

GeneXpert Xpress IV with 4 active modules

Catalogue number GXIV-4-CLIA

Educational Materials


Meet our Game-Changing Platform

With over 36,000 installed systems worldwide, the GeneXpert System is the most popular sample-to-answer PCR testing system. See how it’s helping clinicians everywhere make a more positive impact.

Watch now


Bringing Molecular Testing Closer to the Patient

Over the past 20 years, there has been a continuous shift toward the decentralization of clinical laboratory testing. With recent advances in the speed and accuracy of point-of-care tests, it is now possible to bring molecular infectious disease testing closer to the patient. This webinar explores the benefits of molecular point-of-care testing as a means of improving patient outcomes and quality of care. Currently available testing methods are reviewed, with an emphasis on the importance of lab testing in the era of performance-driven healthcare.



RDT+ASP: How New Rapid Diagnostics are Supercharging Antimicrobial Stewardship Programs

This webinar discusses data supporting the combination of rapid diagnostic tests (RDT) and antimicrobial stewardship programs (ASPs), reviews RDT systems, and provides guidance on how ASPs can implement and optimize the use of RDTs in virtually any healthcare setting.